207 related articles for article (PubMed ID: 27771561)
41. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
42. Human papillomavirus E6 and E7: proteins which deregulate the cell cycle.
Tommasino M; Crawford L
Bioessays; 1995 Jun; 17(6):509-18. PubMed ID: 7575492
[TBL] [Abstract][Full Text] [Related]
43. TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy.
Hu Z; Ding W; Zhu D; Yu L; Jiang X; Wang X; Zhang C; Wang L; Ji T; Liu D; He D; Xia X; Zhu T; Wei J; Wu P; Wang C; Xi L; Gao Q; Chen G; Liu R; Li K; Li S; Wang S; Zhou J; Ma D; Wang H
J Clin Invest; 2015 Jan; 125(1):425-36. PubMed ID: 25500889
[TBL] [Abstract][Full Text] [Related]
44. [The analysis of human papillomavirus type 16 E6/E7 genetic variability in Yunnan Province, China].
Yang LJ; Yue YF; Chen JY; Pan Y; Zhao YJ; Ma SH; Sun QM
Bing Du Xue Bao; 2012 Nov; 28(6):645-51. PubMed ID: 23367564
[TBL] [Abstract][Full Text] [Related]
45. Both Rb and E7 are regulated by the ubiquitin proteasome pathway in HPV-containing cervical tumor cells.
Wang J; Sampath A; Raychaudhuri P; Bagchi S
Oncogene; 2001 Aug; 20(34):4740-9. PubMed ID: 11498796
[TBL] [Abstract][Full Text] [Related]
46. Distribution of human papilloma virus type 16 E6/E7 gene mutation in cervical precancer or cancer: A case control study in Guizhou Province, China.
Yang Y; Ren J; Zhang Q
J Med Virol; 2016 Feb; 88(2):345-50. PubMed ID: 26192265
[TBL] [Abstract][Full Text] [Related]
47. A naturally occurring variant of HPV-16 E7 exerts increased transforming activity through acquisition of an additional phospho-acceptor site.
Zine El Abidine A; Tomaić V; Bel Haj Rhouma R; Massimi P; Guizani I; Boubaker S; Ennaifer E; Banks L
Virology; 2017 Jan; 500():218-225. PubMed ID: 27829177
[TBL] [Abstract][Full Text] [Related]
48. The E2F5 repressor is an activator of E6/E7 transcription and of the S-phase entry in HPV18-associated cells.
Teissier S; Pang CL; Thierry F
Oncogene; 2010 Sep; 29(36):5061-70. PubMed ID: 20639900
[TBL] [Abstract][Full Text] [Related]
49. p53 degradation activity, expression, and subcellular localization of E6 proteins from 29 human papillomavirus genotypes.
Mesplède T; Gagnon D; Bergeron-Labrecque F; Azar I; Sénéchal H; Coutlée F; Archambault J
J Virol; 2012 Jan; 86(1):94-107. PubMed ID: 22013048
[TBL] [Abstract][Full Text] [Related]
50. Genus specific features of bovine papillomavirus E6, E7, E5 and E8 proteins.
Tomita Y; Ogawa T; Jin Z; Shirasawa H
Virus Res; 2007 Mar; 124(1-2):231-6. PubMed ID: 17126443
[TBL] [Abstract][Full Text] [Related]
51. Human papillomavirus E6 proteins mediate resistance to interferon-induced growth arrest through inhibition of p53 acetylation.
Hebner C; Beglin M; Laimins LA
J Virol; 2007 Dec; 81(23):12740-7. PubMed ID: 17898049
[TBL] [Abstract][Full Text] [Related]
52. Human papillomavirus type 16 variant analysis of E6, E7, and L1 genes and long control region in biopsy samples from cervical cancer patients in north India.
Pande S; Jain N; Prusty BK; Bhambhani S; Gupta S; Sharma R; Batra S; Das BC
J Clin Microbiol; 2008 Mar; 46(3):1060-6. PubMed ID: 18199779
[TBL] [Abstract][Full Text] [Related]
53. Differential localization of HPV16 E6 splice products with E6-associated protein.
Vaeteewoottacharn K; Chamutpong S; Ponglikitmongkol M; Angeletti PC
Virol J; 2005 Jun; 2():50. PubMed ID: 15960845
[TBL] [Abstract][Full Text] [Related]
54. Structures of a human papillomavirus (HPV) E6 polypeptide bound to MAGUK proteins: mechanisms of targeting tumor suppressors by a high-risk HPV oncoprotein.
Zhang Y; Dasgupta J; Ma RZ; Banks L; Thomas M; Chen XS
J Virol; 2007 Apr; 81(7):3618-26. PubMed ID: 17267502
[TBL] [Abstract][Full Text] [Related]
55. Association of E6AP (UBE3A) with human papillomavirus type 11 E6 protein.
Brimer N; Lyons C; Vande Pol SB
Virology; 2007 Feb; 358(2):303-10. PubMed ID: 17023019
[TBL] [Abstract][Full Text] [Related]
56. MAML1-induced HPV E6 oncoprotein stability is required for cellular proliferation and migration of cervical tumor-derived cells.
Skelin J; Đukić A; Filić V; Hufbauer M; Akgül B; Thomas M; Banks L; Tomaić V
J Med Virol; 2023 Mar; 95(3):e28624. PubMed ID: 36852660
[TBL] [Abstract][Full Text] [Related]
57. Disruption of pocket protein dream complexes by E7 proteins of different types of human papillomaviruses.
Nor Rashid N; Yusof R; Watson RJ
Acta Virol; 2013; 57(4):447-51. PubMed ID: 24294959
[TBL] [Abstract][Full Text] [Related]
58. Destabilization of TIP60 by human papillomavirus E6 results in attenuation of TIP60-dependent transcriptional regulation and apoptotic pathway.
Jha S; Vande Pol S; Banerjee NS; Dutta AB; Chow LT; Dutta A
Mol Cell; 2010 Jun; 38(5):700-11. PubMed ID: 20542002
[TBL] [Abstract][Full Text] [Related]
59. Cancer susceptibility of beta HPV49 E6 and E7 transgenic mice to 4-nitroquinoline 1-oxide treatment correlates with mutational signatures of tobacco exposure.
Viarisio D; Robitaille A; Müller-Decker K; Flechtenmacher C; Gissmann L; Tommasino M
Virology; 2019 Dec; 538():53-60. PubMed ID: 31569015
[TBL] [Abstract][Full Text] [Related]
60. Structural insights into a wildtype domain of the oncoprotein E6 and its interaction with a PDZ domain.
Mischo A; Ohlenschläger O; Hortschansky P; Ramachandran R; Görlach M
PLoS One; 2013; 8(4):e62584. PubMed ID: 23638119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
